For trips exceeding five days, pausing the protocol is safer than risking temperature-related degradation
Kipnis said that more studies are needed to know what happens when someone stops taking these medications
GLP-1 receptor agonists also slow gastric emptying, reduce appetite through central nervous system pathways, and promote satiety, leading to reduced caloric intake and weight loss
Bauer DE, Hatzivassiliou G, Zhao F, Andreadis C, Thompson CB
G.et al (2019)
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating the neuroprotective effects of semaglutide in early Alzheimers disease